Shaping Schizophrenia Care: Unveiling the Impact of Cognitive Impairment

John M. Kane, MD, and Erin Crown, PA-C, CAQ-Psychiatry, introduce themselves and provide an overview of schizophrenia, highlighting the burden, stigma, prevalence, and the three symptom domains.

Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, provide clinical insights on the treatment of the three symptom domains of schizophrenia, highlighting their manifestations and treatments, including iclepertin.

Two experts in the management of schizophrenia provide further insights on the disease pathophysiology, highlight the inflammatory impact on dendritic spines, and explore treatment considerations for this condition.

Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, discuss awareness among physicians of the concept of cognitive impairment associated with schizophrenia and detail unmet needs, including the lack of approved therapies, measurement tools, and access to cognitive remediation.

A comprehensive discussion on new treatment options for patients with schizophrenia, highlighting the potential for earlier intervention to optimize treatment outcomes.

John M. Kane, MD, and Erin Crown, PA-C, CAQ-Psychiatry, provide closing thoughts on improving schizophrenia care in the future, highlighting the importance of personalizing treatment, shared decision-making, treatment recommendations, and keeping patients engaged.